The increasing interest in successful weight management has led to considerable investigation into cutting-edge treatments. Recently , Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has demonstrated promising results in clinical trials, implying potential for significant weight loss . Therefore, several indi